“Necrotising soft-tissue infection”的搜索结果，显示 161-170 项，共有 10697 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary objective of the trial is to evaluate if L19TNF in combination with doxorubicin (Arm 2) given for unresectable or metastatic soft tissue sarcoma ...

2. 葡萄球菌感染- 医生与科室- 妙佑医疗国际

   Infectious Disease Specialist, Internist. Rochester, MN ...

3. 外科 - 医生 - 妙佑医疗国际

   tumor surgery, Soft tissue sarcoma surgery ... infection, Pelvic bone tumor, Failed total knee ... Necrotizing fasciitis, Volvulus. 显示更多擅长领域 ...

4. 血液科- 临床试验- 妙佑医疗国际

   The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or Refractory Non-Hodgkin Lymphoma ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary objective of the trial is to evaluate if L19TNF in combination with doxorubicin (Arm 2) given for unresectable or metastatic soft tissue sarcoma ...

6. 传染病- 临床试验- 妙佑医疗国际

   Evaluate morbidity and mortality associated with infection complications in MCAD recipients. Lymphoid Tissue Examination. Rochester, Minn. The purpose of this ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... soft-tissue sarcoma patients. In the study, 122 patients will be randomized in a 1:1 ratio to receive doxorubicin treatment (Arm 1) or L19TNF treatment in ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Tissue Reinforcement For Breast Reconstruction (TRBR) Pivotal Clinical Study (REDEFINE) ... soft tissue sarcoma (STS) tissue and tissue data ... infection rates.

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... soft-tissue sarcoma patients. In the study, 122 patients will be randomized in a 1:1 ratio to receive doxorubicin treatment (Arm 1) or L19TNF treatment in ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    The primary objective of the trial is to evaluate if L19TNF in combination with doxorubicin (Arm 2) given for unresectable or metastatic soft tissue sarcoma ...